United States· US:55289-075_4199686c-7009-b215-e063-6294a90aaa02
Erythromycin
A erythromycin product containing erythromycin, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Erythromycin is registered in 13 of 19 countries.
Countries holding a registration under ATC J01FA01 (erythromycin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Erythromycin · ATC J01FA01
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ERYTHROMYCIN
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- J01FA01
- ATC class
- Erythromycin
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1155289075033 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-03)
- ndc11552890754040 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-40)
- ndc11552890755656 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-56)
- ndc1155289-075-40
- ndc1155289-075-03
- ndc1155289-075-56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1011 interactions on record for erythromycin.
Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Erythromycin · interactions on record
1011 records
- 216 severe
- 424 moderate
- 70 minor
- 227 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
74 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Erythromycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayErythrocinAmdipharm UK Limited
- FinlandAbboticinAbbott Scandinavia AB
- IrelandErythrocin 250 mg tabletsAmdipharm Limited
- SwedenAbboticin 250 mg Filmdragerad tablettAmdipharm Limited
- United KingdomEryacne 2 gelGalderma (UK) Ltd
- PolandAknemycinLaboratorium Galenowe Olsztyn Sp. z o.o.
- SpainDERIPIL GELLaboratorio Reig Jofre, S.A.
- FranceERY 500 mg, compriméBOUCHARA-RECORDATI
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Belgium · Erycine, Erythrocine
- Cyprus · Ermyced, Ermycin
- Czechia · Aknemycin
- Germany · Aknemycin, Erythromycin Panpharma
- Denmark · Abboticin, Erythromycin Panpharma
- Spain · Eritromicina Panpharma, Oftalmolosa Cusí Eritromicina
- Finland · Abboticin, Abboticin Novum
- France · Ery, Ery Nourrissons
- United Kingdom (Northern Ireland) · Erythrocin 250, Erythrocin 500
- Greece · Acne Hermal, Dankit
- Croatia · Eritromicin Belupo
- Hungary · Aknemycin
- Ireland · Erythrocin
- Italy · Eritromicina Idi
- Lithuania · Erythromycin Tc
- Luxembourg · Aknemycin, Ery
- Latvia · Erythromycin Tzf
- Netherlands · Erythrocine, Erythrocine Es
- Norway · Abboticin, Ery-Max
- Poland · Aknemycin, Cusi
- Portugal · Akne-Mycin, Clinac
- Romania · Eritromicină Atb
- Sweden · Abboticin, Abboticin Novum
- Slovakia · Aknemycin, Aknemycin 2000
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c38fbc9c-2ea6-430c-ad12-5abb7ed72709 GET /v1/drugs/c38fbc9c-2ea6-430c-ad12-5abb7ed72709?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "250",
"substance": "ERYTHROMYCIN",
"productndc": "55289-075",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA061621",
"marketing_category": "ANDA"
}See everything about erythromycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.